Variables | β | z | HR (95%CI) | P value |
---|---|---|---|---|
Gender (Male/Female) | 1.46 | 3.57 | 3.31 [1.52, 7.20] | 0.003 |
Drinking History | 1.13 | 3.16 | 0.37 [0.18, 0.73] | 0.004 |
Complications | 0.66 | 2.2 | 0.49 [0.26, 0.92] | 0.025 |
Tumor size (>2.5 cm/≤2.5 cm) | 0.51 | 1.6 | 1.38 [0.73, 2.61] | 0.084 |
CA19-9 (>54.87/≤54.87) | 1.17 | 2.87 | 3.51 [1.33, 9.24] | 0.011 |
CA19-9/GGT (>0.15/≤0.15) | 0.80 | 2.11 | 8.19 [3.37, 19.92] | < 0.001 |
PLR (>265.81/≤265.81) | 0.36 | 1.11 | 1.49 [0.77, 2.88] | 0.237 |
GPR (>3.75/≤3.75) | -0.59 | -1.46 | 0.64 [0.29, 1.40] | 0.264 |
AJCC 8th edition TNM stage | 0.25 | 1.94 | 0.97 [0.46, 2.07] | 0.054 |
IB | 0.73 | 0.49 | 1.89 [0.09, 10.66] | 0.077 |
IIA | 0.77 | 0.6 | 3.68 [0.14, 4.71] | 0.056 |
IIB | 1.58 | 1.16 | 0.97 [0.03, 3.55] | 0.087 |
IIIA | 1.78 | 1.31 | 0.52 [0.18, 1.56] | 0.146 |
Diferentiation | 0.40 | 1.31 | 2.08 [0.82, 5.28] | 0.067 |
II | 0.13 | 0.13 | 1.49 [0.82, 2.69] | 0.049 |
III | 1.02 | 1.01 | 1.50 [0.66, 3.43] | 0.135 |
Lymph node invasion | 2.30 | 1.42 | 2.30 [0.91, 5.79] | 0.068 |